Logo image of FRS.DE

FORIS AG (FRS.DE) Stock Fundamental Analysis

FRA:FRS - Deutsche Boerse Ag - DE0005775803 - Common Stock - Currency: EUR

3.36  -0.08 (-2.33%)

Fundamental Rating

4

Taking everything into account, FRS scores 4 out of 10 in our fundamental rating. FRS was compared to 50 industry peers in the Financial Services industry. No worries on liquidiy or solvency for FRS as it has an excellent financial health rating, but there are worries on the profitability. FRS has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year FRS was profitable.
In the past year FRS had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: FRS reported negative net income in multiple years.
In the past 5 years FRS reported 4 times negative operating cash flow.
FRS.DE Yearly Net Income VS EBIT VS OCF VS FCFFRS.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M 4M

1.2 Ratios

FRS's Return On Assets of 9.72% is amongst the best of the industry. FRS outperforms 82.00% of its industry peers.
FRS has a Return On Equity of 13.00%. This is comparable to the rest of the industry: FRS outperforms 60.00% of its industry peers.
FRS's Return On Invested Capital of 10.54% is fine compared to the rest of the industry. FRS outperforms 80.00% of its industry peers.
Industry RankSector Rank
ROA 9.72%
ROE 13%
ROIC 10.54%
ROA(3y)-1.31%
ROA(5y)-1.33%
ROE(3y)-1.51%
ROE(5y)-1.57%
ROIC(3y)N/A
ROIC(5y)N/A
FRS.DE Yearly ROA, ROE, ROICFRS.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 10 -10 -15

1.3 Margins

The Profit Margin of FRS (8.38%) is comparable to the rest of the industry.
The Operating Margin of FRS (9.65%) is comparable to the rest of the industry.
FRS's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 25.86%, FRS is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
FRS's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 9.65%
PM (TTM) 8.38%
GM 25.86%
OM growth 3YN/A
OM growth 5Y1.97%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.69%
GM growth 5Y-4.82%
FRS.DE Yearly Profit, Operating, Gross MarginsFRS.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20 30

More info and screens

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), FRS is creating some value.
The number of shares outstanding for FRS remains at a similar level compared to 1 year ago.
The number of shares outstanding for FRS has been reduced compared to 5 years ago.
FRS has a better debt/assets ratio than last year.
FRS.DE Yearly Shares OutstandingFRS.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M
FRS.DE Yearly Total Debt VS Total AssetsFRS.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

2.2 Solvency

FRS has an Altman-Z score of 3.90. This indicates that FRS is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 3.90, FRS is doing good in the industry, outperforming 74.00% of the companies in the same industry.
There is no outstanding debt for FRS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 1.9
Altman-Z 3.9
ROIC/WACC1.65
WACC6.4%
FRS.DE Yearly LT Debt VS Equity VS FCFFRS.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M 10M 15M

2.3 Liquidity

A Current Ratio of 3.19 indicates that FRS has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 3.19, FRS belongs to the top of the industry, outperforming 88.00% of the companies in the same industry.
A Quick Ratio of 1.60 indicates that FRS should not have too much problems paying its short term obligations.
FRS has a Quick ratio of 1.60. This is in the better half of the industry: FRS outperforms 78.00% of its industry peers.
Industry RankSector Rank
Current Ratio 3.19
Quick Ratio 1.6
FRS.DE Yearly Current Assets VS Current LiabilitesFRS.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M

More info and screens

3

3. Growth

3.1 Past

FRS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 79.83%, which is quite impressive.
The Revenue has grown by 17.83% in the past year. This is quite good.
The Revenue has been growing slightly by 2.64% on average over the past years.
EPS 1Y (TTM)79.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%132.8%
Revenue 1Y (TTM)17.83%
Revenue growth 3Y10.69%
Revenue growth 5Y2.64%
Sales Q2Q%32.17%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
FRS.DE Yearly Revenue VS EstimatesFRS.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M
FRS.DE Yearly EPS VS EstimatesFRS.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 6.86, the valuation of FRS can be described as very cheap.
Based on the Price/Earnings ratio, FRS is valued a bit cheaper than the industry average as 78.00% of the companies are valued more expensively.
FRS is valuated cheaply when we compare the Price/Earnings ratio to 29.35, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 6.86
Fwd PE N/A
FRS.DE Price Earnings VS Forward Price EarningsFRS.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, FRS is valued a bit cheaper than the industry average as 74.00% of the companies are valued more expensively.
78.00% of the companies in the same industry are more expensive than FRS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 6.85
EV/EBITDA 6.56
FRS.DE Per share dataFRS.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

FRS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FORIS AG

FRA:FRS (3/7/2025, 7:00:00 PM)

3.36

-0.08 (-2.33%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)N/A N/A
Earnings (Next)03-27 2025-03-27
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners17.82%
Ins Owner ChangeN/A
Market Cap15.56M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 6.86
Fwd PE N/A
P/S 0.58
P/FCF 6.85
P/OCF 6.46
P/B 0.9
P/tB 0.91
EV/EBITDA 6.56
EPS(TTM)0.49
EY14.58%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.49
FCFY14.6%
OCF(TTM)0.52
OCFY15.49%
SpS5.78
BVpS3.73
TBVpS3.68
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 9.72%
ROE 13%
ROCE 14.97%
ROIC 10.54%
ROICexc 11.65%
ROICexgc 11.8%
OM 9.65%
PM (TTM) 8.38%
GM 25.86%
FCFM 8.49%
ROA(3y)-1.31%
ROA(5y)-1.33%
ROE(3y)-1.51%
ROE(5y)-1.57%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-2.53%
ROICexc growth 3YN/A
ROICexc growth 5Y0.54%
OM growth 3YN/A
OM growth 5Y1.97%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.69%
GM growth 5Y-4.82%
F-Score7
Asset Turnover1.16
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 1.9
Debt/EBITDA 0
Cap/Depr 76.37%
Cap/Sales 0.52%
Interest Coverage 250
Cash Conversion 87.19%
Profit Quality 101.25%
Current Ratio 3.19
Quick Ratio 1.6
Altman-Z 3.9
F-Score7
WACC6.4%
ROIC/WACC1.65
Cap/Depr(3y)42.82%
Cap/Depr(5y)30.6%
Cap/Sales(3y)0.46%
Cap/Sales(5y)0.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)79.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%132.8%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)17.83%
Revenue growth 3Y10.69%
Revenue growth 5Y2.64%
Sales Q2Q%32.17%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y74.81%
EBIT growth 3YN/A
EBIT growth 5Y4.65%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y208.51%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y217.16%
OCF growth 3YN/A
OCF growth 5YN/A